Stock A008930 HANMI SCIENCE CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hanmi Science Co., Ltd.

Equities

A008930

KR7008930000

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
33,300 KRW -1.33% Intraday chart for Hanmi Science Co., Ltd. +1.83% -15.05%
Apr. 08 Hanmi Science Co., Ltd. cancelled the transaction announced on January 12, 2024 CI
Mar. 28 OCI Holdings Company Ltd. cancelled the acquisition of 10.94% stake in Hanmi Science Co., Ltd. from Song Young Sook, Kim Won Se and Kim JI Woo. CI

Business Summary

Hanmi Science Co Ltd is a Korean-based holding company principally involved in the management of subsidiaries. Through subsidiaries in Japan, Europe and Korea, the Company operates in three segments. The Pharmaceutical Products Wholesale segment mainly engages in the distribution of pharmaceutical products. The Holding Business segment mainly engages in the business of controlling subsidiaries. The Other segment mainly engage in the production and sales of pharmaceuticals, and the supply of quasi-drugs and health functional foods, beverages and functional cosmetics.

Number of employees: 403

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceutical Wholesale
85.8 %
989,914 94.6 % 1,070,376 85.8 % +8.13%
Healthcare
8.9 %
- - 110,938 8.9 % -
Holding
4.1 %
51,745 4.9 % 51,236 4.1 % -0.98%
Other
1.2 %
4,396 0.4 % 15,356 1.2 % +249.33%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
97.1 %
1,036,996 99.1 % 1,211,816 97.1 % +16.86%
China
2.7 %
8,741 0.8 % 33,860 2.7 % +287.40%
Other
0.2 %
318 0.0 % 2,230 0.2 % +601.60%

Managers

Managers TitleAgeSince
Young-Sook Song CEO
 Chief Executive Officer 76 -
Jong-Hoon Lim CEO
 Chief Executive Officer 47 Apr. 03
Ki-Ho Song DFI
 Director of Finance/CFO 52 -
Ji-Seon Nam CMP
 Compliance Officer 40 17-06-19
Jong-Yoon Lim BRD
 Director/Board Member 51 -
Gyu-Sik Kim PRN
 Corporate Officer/Principal 57 -
Ju-Hyun Lim PRN
 Corporate Officer/Principal 49 20-08-31

Members of the board

Members of the board TitleAgeSince
Jong-Yoon Lim BRD
 Director/Board Member 51 -
Ju-Hyun Lim
49 -
Jong-Hoon Lim CEO
 Chief Executive Officer 47 Apr. 03
Young-Sook Song CEO
 Chief Executive Officer 76 -
Yu-Cheol Shin BRD
 Director/Board Member 59 19-03-14
Yong-Duk Kim BRD
 Director/Board Member 67 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 69,956,940 19,940,484 ( 28.50 %) 2,193,277 ( 3.135 %) 28.50 %

Shareholders

NameEquities%Valuation
Young-Sook Song
12.56 %
8,789,671 12.56 % 250 M ₩
Jong-Hoon Lim
10.56 %
7,389,428 10.56 % 210 M ₩
Jong-Yoon Lim
9.913 %
6,935,031 9.913 % 197 M ₩
Ju-Hyun Lim
7.292 %
5,101,306 7.292 % 145 M ₩
National Pension Service of Korea
7.087 %
4,958,047 7.087 % 141 M ₩
La Defense Partners Co. Ltd.
6.263 %
4,381,590 6.263 % 125 M ₩
Corus Ltd.
5.518 %
3,860,527 5.518 % 110 M ₩
Gahyun Cultural Foundation
4.904 %
3,430,885 4.904 % 98 M ₩
Lim Sung-Ki Foundation
3.004 %
2,101,191 3.004 % 60 M ₩
HANMI SCIENCE CO., LTD.
2.803 %
1,960,883 2.803 % 56 M ₩

Holdings

NameEquities%Valuation
HANMI PHARM. CO., LTD.
41.42%
 5,306,122 41.42% 1,312,489,228 $
JVM CO., LTD.
39.19%
 4,738,544 39.19% 103,834,388 $
HANMI SCIENCE CO., LTD.
2.80%
 1,960,883 2.80% 55,785,945 $

Company contact information

Hanmi Science Co., Ltd.

214 Muha-ro Paltan-myeon

18536, Hwaseong-si

+

http://www.hanmi.co.kr
address Hanmi Science Co., Ltd.(A008930)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sales per region

Sector Generic Pharmaceuticals

1st Jan change Capi.
HANMI SCIENCE CO., LTD. Stock Hanmi Science Co., Ltd.
-15.05% 1.64B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.89B
SANDOZ GROUP AG Stock Sandoz Group AG
+8.80% 14.45B
CIPLA LIMITED Stock Cipla Limited
+13.07% 13.63B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+37.46% 11.49B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.85B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+6.35% 5.06B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. Stock Shenzhen Salubris Pharmaceuticals Co., Ltd.
-5.36% 4.66B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A008930 Stock
  4. Company Hanmi Science Co., Ltd.